Employees
Employee count
ESG framework mentions
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
8-K
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
1 Apr 24
8-K
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
1 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Pricing of $5.5 Million Public Offering
2 Feb 24
8-K
GRI Bio Announces Reverse Stock Split
30 Jan 24
8-K
GRI Bio Announces Reverse Stock Split
30 Jan 24
8-K
GRI Bio Announces Reverse Stock Split
30 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
19 Jan 24
8-K
Regulation FD Disclosure
16 Jan 24
8-K
Regulation FD Disclosure
16 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Jan 24
DEF 14A
Definitive proxy
29 Dec 23
8-K
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway
5 Dec 23
8-K
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway
5 Dec 23
8-K
Clinical development plan leveraging 505(b)(2) regulatory pathway
27 Nov 23
8-K
Clinical development plan leveraging 505(b)(2) regulatory pathway
27 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Nov 23
8-K
Phase 2a biomarker study of GRI-0621 for Idiopathic Pulmonary Fibrosis ("IPF") on track to start before year end 2023; Interim data expected H1 2024
15 Nov 23
8-K
Phase 2a biomarker study of GRI-0621 for Idiopathic Pulmonary Fibrosis ("IPF") on track to start before year end 2023; Interim data expected H1 2024
15 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Regulation FD Disclosure
1 Nov 23
8-K
Regulation FD Disclosure
25 Aug 23
8-K
Regulation FD Disclosure
25 Aug 23
8-K
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
23 Aug 23
8-K
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
23 Aug 23
8-K
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
23 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
AgricultureCleanClimate ChangeEnvironmentEnvironmentalEnvironmental ProtectionExtreme WeatherIntensityMaterialsNatural ResourcesNatureOffsetPackagePackagingPandemicRaw MaterialsWasteAccessAfrican AmericanAsianAttritionBenefitsBlackCalifornia Consumer Privacy ActCharitableCommunityCustomerCyberCybersecurityData PrivacyData SecurityDeathDemographicDisabilityDiversityDrug PricingEmployeeEngagementEthnicityGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHispanicHuman CapitalIncidentInjuryLatinxLGBTQMinorityPrivacyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySatisfactionSkillSkilledSkillsSocialSocietalSocietyStakeholderSupplierSupply ChainTrainingUnionVolunteerWomenWorking ConditionAction PlanAnti-corruptionAssessmentAssuranceAuditBonusBribeChronicClassifiedClawbackCommitmentConflict of InterestCorporate GovernanceDepartment ofEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentIndependent ChairInnovationInnovativeInvestigationLawsuitLeadershipLitigationLong-termMajorityMissionOverseeOversightPledgingPurposeQuality StandardR&DReputationReputationalResearch and DevelopmentResponsibilityResponsibleSpecial MeetingStewardshipStrategyTargetsTaxTransparencyTransparentVoting Rights